Suchergebnisse - "Harsløf, Torben"

PubPharm (80)

1

Racial differences as an explanation of observed differences in bone tissue stiffness, hardness, and bone turnover markers

enthalten in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research | 2024

von Starup-Linde, J. | Bardenfleth, H. | Harsløf, T. | +1

2

Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves' orbitopathy

enthalten in: Endocrine | 2023

von Harsløf, T. | Hikmet, R. | Ebbehøj, E. | +1

3

The Effect of Effervescent and Buffered Alendronate Compared to Conventional Alendronate on Markers of Bone Turnover : A Randomized Non-inferiority Trial

enthalten in: Calcified tissue international | 2023

von Hikmet, R. | Harsløf, T. | Langdahl, B.

4

Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2023

von Sølling, A. | Harsløf, T. | Jørgensen, N. | +1

5

Denosumab Discontinuation

enthalten in: Current osteoporosis reports | 2023

von Sølling, A. | Tsourdi, E. | Harsløf, T. | +1

6

Discontinuation of denosumab in men with prostate cancer

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2023

von Sølling, A. | Harsløf, T. | Brockstedt, H. | +1

7

Denosumab Discontinuation

enthalten in: Current osteoporosis reports | 2022

von Sølling, A. | Tsourdi, E. | Harsløf, T. | +1

8

Denosumab Discontinuation

enthalten in: Current osteoporosis reports | 2022

von Sølling, A. | Tsourdi, E. | Harsløf, T. | +1

9

Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption

enthalten in: Osteoporosis international | 2022

von Sølling, A. | Harsløf, T. | Jørgensen, N. | +1

10

Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption

enthalten in: Osteoporosis international | 2022

von Sølling, A. | Harsløf, T. | Jørgensen, N. | +1

1
2
3
4
5
6
7
8
Nächster »
[8]